ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1549

Prevalence Of Syndesmophytes In Patients With Chronic Back Pain Suspected Of Axial Spondyloarthritis (axSpA) Not Fulfilling The Modified New York (mNY) Criteria

Manouk de Hooge1, Rosaline van den Berg2, Floris van Gaalen2, Monique Reijnierse3, Victoria Navarro-Compán2, Karen Fagerli4, Maureen C. Turina5, Maikel van Oosterhout6, Roberta Ramonda7, Tom Huizinga2 and Désiréé van der Heijde1, 1Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Radiology, Leiden University Medical Center, Leiden, Netherlands, 4Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 5Department of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 6Rheumatology, GHZ Hospital, Gouda, Netherlands, 7Rheumatology Unit, University of Padova, Padova, Italy

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: spondylarthritis and x-ray

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment: II

Session Type: Abstract Submissions (ACR)

Background/Purpose: The mNY criteria1, which indicate sacroiliitis of at least grade 2 bilaterally or grade 3 or 4 unilaterally, are used to classify patients as Ankylosing Spondylitis (AS). However, little is known about the occurrence of syndesmophytes in the spine in the absence of radiographic sacroiliitis. Therefore we want to investigate if syndesmophytes are prevalent in patients with chronic back pain suspected of axSpA who are not fulfilling the mNY criteria and if syndesmophytes should be included in criteria to define patients as having radiographic axSpA.

Methods: Patients with back pain (≥3 months, ≤2 years, onset ≤45 years) recruited from the 5 participating centres across Europe were included in the SPondyloArthritis Caught Early (SPACE)-cohort. All patients underwent conventional radiographs of the cervical and lumbar spine and sacroiliac (SI)-joints (X-spine and X-SI, respectively). X-spine was scored on the presence or absence of ≥1 syndesmophytes, X-SI was scored according to the mNY1. X-rays were scored independently by 3 well-calibrated readers. Lesions on x-ray were considered present if 2/3 readers agreed.

Results: All patients with both X-spine and X-SI data available (n=302) were used for comparison. There were 26 patients (8.6%) fulfilling the mNY criteria and 7 patients (2.3%) with ≥1 syndesmophytes present in the spine. None of those 7 patients showed radiographic sacroiliitis nor active lesions on MRI of the SI joints. Two patients fulfil the ASAS axSpA criteria and 5 patients had SpA features without fulfilling the ASAS axSpA criteria. In table 1 the number and location of syndesmophytes and SpA features are presented. Most patients (n=5) had 1 syndesmophyte. The two patients with >1 syndesmophytes did not fulfil the ASAS axSpA criteria.  All patients had syndesmophytes located solely in the cervical part of the spine. None of the patients had psoriasis. Only 2/302 (0.7%) patients would be considered as having signs of radiographic axSpA if syndesmophytes (in absence of radiographic sacroiliitis) would be considered a sign of radiographic involvement.

There were 2 patients (italic in table) in whom corresponding syndesmophytes on the MRI of the spine were scored by both readers.

Conclusion: In this population, syndesmophytes in patients without sacroiliitis on radiographs and MRI are infrequent and solely located in the cervical spine. Indicating that syndesmophytes are not informative in classifying patients as having radiographic axSpA in early disease.

References 1van der Linden S A&R 984;27:361–8

No. of synd.

Location of synd.

No. of SpA features

SpA features

ASAS axSpA criteria

1

cervical

2

IBP+ESR

no

1

cervical

2

IBP+NSAIDs

no

1

cervical

4

IBP+NSAIDs+HLA-B27+pos. fam. hist.

yes

1

cervical

4

IBP+NSAIDs+HLA-B27+pos. fam. hist.

yes

1

cervical

7

IBP+NSAIDs+heel pain+dact.+IBD+ESR+peripheral arthritis

no

2

cervical

2

IBP+NSAIDs

no

3

cervical

1

HLA-B27

no

IBP; inflammatory back pain, ESR; elevated erythrocyte sedimentation rate and/or C-reactive protein, NSAIDs; good response to non-steroidal anti-inflammatory drugs, HLA-B27; Human Leukocyte Antigen B27, pos. fam. hist.; positive family history, dact; dactylitis, IBD; inflammatory bowel disease.


Disclosure:

M. de Hooge,
None;

R. van den Berg,
None;

F. van Gaalen,
None;

M. Reijnierse,
None;

V. Navarro-Compán,
None;

K. Fagerli,
None;

M. C. Turina,
None;

M. van Oosterhout,
None;

R. Ramonda,
None;

T. Huizinga,
None;

D. van der Heijde,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-syndesmophytes-in-patients-with-chronic-back-pain-suspected-of-axial-spondyloarthritis-axspa-not-fulfilling-the-modified-new-york-mny-criteria/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology